Protagonist Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
CEODinesh V. Patel
CEODinesh V. Patel
Employees126
Employees126
HeadquartersNewark, California
HeadquartersNewark, California
Founded2006
Founded2006
Employees126
Employees126
PTGX Key Statistics
Market cap3.37B
Market cap3.37B
Price-Earnings ratio70.75
Price-Earnings ratio70.75
Dividend yield—
Dividend yield—
Average volume893.50K
Average volume893.50K
High today$54.97
High today$54.97
Low today$53.11
Low today$53.11
Open price$54.27
Open price$54.27
Volume1.07M
Volume1.07M
52 Week high$60.60
52 Week high$60.60
52 Week low$30.67
52 Week low$30.67
PTGX News
Simply Wall St 2d
Exploring Three High Growth Tech Stocks In The US MarketThe United States market has shown a positive trend, climbing 1.4% in the last week and rising 12% over the past year, with earnings projected to grow by 15% an...
Analyst ratings
91%
of 11 ratingsBuy
90.9%
Hold
9.1%
Sell
0%
People also own
Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.